PETMED EXPRESS INC (PETS)
About PETMED EXPRESS INC
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2026
- $179.0M
- Net income
- -$57.3M
- Total assets
- $81.2M
- Market cap
- $35.9M
- Gross margin
- 28.1%
- Operating margin
- -32.8%
- Net margin
- -32.0%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $179.0M
- Cost of revenue
- $128.8M
- Gross profit
- $50.2M
- Operating expenses
- $108.9M
- Operating income
- -$58.7M
- Income tax
- -$73.0K
- Net income
- -$57.3M
- EPS (basic)
- $-2.74
- EPS (diluted)
- $-2.74
Balance sheet
- Total assets
- $81.2M
- Current assets
- $43.6M
- Total liabilities
- $52.3M
- Current liabilities
- $52.0M
- Shareholders’ equity
- $28.9M
Cash flow
- Operating cash flow
- -$28.4M
- Investing cash flow
- -$4.6M
- Financing cash flow
- -$299.0K
- Net cash flow
- -$33.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $35.9M
- EPS (diluted)
- $-2.74
- Dividend yield
- 60.3%
- Shares outstanding
- 18.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 17, 1997
Petmed Express Inc (PETS) Stock Price
- Reported a net loss of $57.3M in FY2026.
- Revenue declined 35% from FY2022 to FY2026.
- Gross margin of 28.1%, net margin -32.0%.
- Trading 50% below its 52-week high.
- Pays a dividend yielding about 60.3% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PETMED EXPRESS INC.
Write a review
News about PETMED EXPRESS INC
News & sentiment via Polygon.io
Petmed Express Inc: frequently asked questions
Is Petmed Express Inc an American company?
Petmed Express Inc is a US-based company headquartered in Delray Beach, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Petmed Express Inc headquartered?
Petmed Express Inc is headquartered in Delray Beach, Florida, United States.
Is Petmed Express Inc publicly traded?
Yes — Petmed Express Inc is a publicly traded company. Its stock trades under the ticker symbol PETS on the NASDAQ.
